> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CBER Considering 11 Guidances in 2016
- URL: https://www.fdaweb.com/cber-considering-11-guidances-in-2016/
- Published: 2016-01-21T12:00:00.000Z
- Updated: 2026-09-15T02:29:22.000Z
- Author: David McFarland
- Tags: Biologics, #legacy-id-D5134494

> CBER has published a [list](http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/UCM431409.pdf?ref=fdaweb.com) of 11 guidances in three categories that it is considering for development in the 2016 calendar year. The list includes topics that currently have no guidance associated with them, topics where updated guidance may be helpful, and topic for which the Center has already issued Level 1 drafts that may be finalized following review of public comments.  
>  
> There are six potential guidances listed under Blood and Blood Components; three under Cellular, Tissue, and Gene Therapy; and two under Other.